Coronavirus disease 2019

COVID-19 is a con­ta­gious dise­a­se cau­sed by the coro­na­vi­rus SARS-CoV‑2. In Janu­ary 2020, the dise­a­se spread world­wi­de, resul­ting in the COVID-19 pandemic.

The sym­ptoms of COVID‑19 can vary but often include fever,[7] fati­gue, cough, breathing dif­fi­cul­ties, loss of smell, and loss of taste.[8][9][10] Sym­ptoms may begin one to four­teen days after expo­sure to the virus. At least a third of peo­p­le who are infec­ted do not deve­lop noti­ceable symptoms.[11][12] Of tho­se who deve­lop sym­ptoms noti­ceable enough to be clas­si­fied as pati­ents, most (81%) deve­lop mild to mode­ra­te sym­ptoms (up to mild pneu­mo­nia), while 14% deve­lop seve­re sym­ptoms (dys­pnea, hypo­xia, or more than 50% lung invol­vement on ima­ging), and 5% deve­lop cri­ti­cal sym­ptoms (respi­ra­to­ry fail­ure, shock, or mul­ti­or­gan dysfunction).[13] Older peo­p­le have a hig­her risk of deve­lo­ping seve­re sym­ptoms. Some com­pli­ca­ti­ons result in death. Some peo­p­le con­ti­nue to expe­ri­ence a ran­ge of effects (long COVID) for months or years after infec­tion, and dama­ge to organs has been observed.[14] Mul­ti-year stu­dies on the long-term effects are ongoing.[15]

COVID‑19 trans­mis­si­on occurs when infec­tious par­tic­les are brea­thed in or come into cont­act with the eyes, nose, or mouth. The risk is hig­hest when peo­p­le are in clo­se pro­xi­mi­ty, but small air­bor­ne par­tic­les con­tai­ning the virus can remain sus­pen­ded in the air and tra­vel over lon­ger distances, par­ti­cu­lar­ly indoors. Trans­mis­si­on can also occur when peo­p­le touch their eyes, nose, or mouth after tou­ch­ing sur­faces or objects that have been con­ta­mi­na­ted by the virus. Peo­p­le remain con­ta­gious for up to 20 days and can spread the virus even if they do not deve­lop symptoms.[16]

Test­ing methods for COVID-19 to detect the virus’s nucleic acid include real-time rever­se tran­scrip­ti­on poly­me­ra­se chain reac­tion (RT‑PCR),[17][18] tran­scrip­ti­on-media­ted amplification,[17][18][19] and rever­se tran­scrip­ti­on loop-media­ted iso­ther­mal ampli­fi­ca­ti­on (RT‑LAMP)[17][18] from a nas­opha­ryn­ge­al swab.[20]

Seve­ral COVID-19 vac­ci­nes have been appro­ved and dis­tri­bu­ted in various count­ries, many of which have initia­ted mass vac­ci­na­ti­on cam­paigns. Other pre­ven­ti­ve mea­su­res include phy­si­cal or social distancing, qua­ran­ti­ning, ven­ti­la­ti­on of indoor spaces, use of face masks or cove­rings in public, cove­ring coughs and snee­zes, hand washing, and kee­ping unwa­shed hands away from the face. While drugs have been deve­lo­ped to inhi­bit the virus, the pri­ma­ry tre­at­ment is still sym­pto­ma­tic, mana­ging the dise­a­se through sup­port­i­ve care, iso­la­ti­on, and expe­ri­men­tal measures.